1 Diet Lifestyle and Heart Disease Dr B. Sesikeran, MD, FAMS Director National Institute of...
-
Upload
bertha-ball -
Category
Documents
-
view
216 -
download
1
Transcript of 1 Diet Lifestyle and Heart Disease Dr B. Sesikeran, MD, FAMS Director National Institute of...
1
Diet Lifestyle and Heart Disease
Dr B. Sesikeran, MD, FAMS
DirectorNational Institute of Nutrition
(Indian Council of Medical Research)
Hyderabad – 500 604
2
In India about 60% have silent CHD
Studies conducted from the 1960s to the early 1990s suggested a direct relationship between income and CHD risk
Studies conducted in the last decade have reported an inverse relationship between education and/or income
3
The overall prevalence rate of CAD is 11.0% (age standardized, 9.0%).
The prevalence rates of CAD were 9.1%, 14.9% and 21.4% in those with NGT, IGT and diabetes, respectively.
Prevalence of CAD increased with an increase in total cholesterol ), low-density lipoprotein (LDL) cholesterol, triglycerides and total cholesterol/high-density lipoprotein ratio
Multiple logistic regression analysis identified age (odds ratio [OR]: 1.05, p < 0.001) and LDL cholesterol (OR: 1.009, p = 0.051) as the risk factors for CAD. (Mohan et al)
4
CVD in India
In 2003 prevalence was 3-4% rural and 8-10%
Urban- 2 to 6 times higher than 40yrs back
1990 1.17 million deaths from CHD
In 2010 expected to be 2.03 million
5
CVD in India (Contd…)
Age of onset 10 yrs earlier than in the west
Prevalence of T2DM 2 to 3 times than the west
3.8% rural and 11.8% urban figures
HTN 12.17% rural and 20 -40% urban
6
Despite reductions in cardiovascular disease (CVD)
mortality, current evidence suggests that CVD is not
being prevented but, rather, is being made less lethal.
Several studies of people without established CVD risk
factors (cigarette smoking, diabetes mellitus, elevated
blood pressure, elevated blood cholesterol, and so
forth) demonstrate exceptionally low rates of CVD
incidence.
Rosengren et al; a large proportion of CVD incidence
could be prevented by lifestyle modifications alone.
7
Secondary prevention. has been classically defined as the prevention of disease recurrence and death after the onset of symptomatic disease.
Primary prevention traditionally has been the prevention of the onset of symptomatic disease through the treatment of risk factors for CVD.
Primordial prevention describes efforts to reduce the onset of the risk factors known to predispose people to CVD. For example, lifestyle modifications to maintain ideal body weight and to limit sodium consumption.
Definitions of Types of Prevention
10
Low-density lipoprotein (LDL): LDL, or "bad," cholesterol transports cholesterol particles throughout your body. LDL cholesterol builds up in the walls of your arteries, making them hard and narrow.
Very-low-density lipoprotein (VLDL): This type of lipoprotein contains the most triglycerides, a type of fat, attached to the proteins in your blood. Like LDL cholesterol, VLDL cholesterol makes LDL cholesterol particles larger, causing your blood vessels to narrow. If you're taking cholesterol-lowering medication but have a high VLDL level, you may need additional medication to lower it because VLDL is high in triglycerides.
High-density lipoprotein (HDL): HDL, or "good," cholesterol picks up excess cholesterol and takes it back to your liver.
Types of Cholesterol
11
Total cholesterol
Below 200 mg/dL Desirable
200-239 mg/dL Borderline high
240 mg/dL and above High
LDL cholesterol
Below 70 mg/dL Optimal for people at very high risk of heart disease
Below 100 mg/dLOptimal for people at risk of heart disease
100-129 mg/dL Near optimal
130-159 mg/dL Borderline high
160-189 mg/dL High
190 mg/dL and above Very high
12
HDL cholesterol
Below 40 mg/dL (men)Below 50 mg/dL (women)
Poor
50-59 mg/dL Better
60 mg/dL and above Best
Triglycerides
Below 150 mg/dL Desirable
150-199 mg/dL Borderline high
200-499 mg/dL High
500 mg/dL and above Very high
13
Fats and oils
Glycerides (95%-99%) (Fatty acids)
Non Glyceride components (1%-5%) - Tocopherols & Tocotrienols - Lignans - Sterols - Phenolic compounds - Carotenoids
FATS AND OILS AND THEIR COMPONENTS
14
FATTY ACIDS PRESENT IN FATS/OILS
Saturated fatty acids (SFA)
Monounsaturated fatty acids (MUFA)
cis MUFA
trans MUFAa
Polyunsaturated fatty acids (PUFA)
n-6 PUFA
n-3 PUFA (-linolenic acidb , Long chain n-3
PUFAc)
a Present in hydrogenated fat (Vanaspati)b Present in vegetable oils such as soyabean, mustard, canola, linseed oilsc Active form of n-3 PUFA present in fish and fish oil
15
Fatty acid composition of cooking oils
SFA rich oils Coconut oil ( ~ 90%) Palm oil (~ 48 %) Ghee (~ 65 %)
MUFA rich oils Olive oil (~ 70%) Groundnut oil ( ~ 50%) Palm oil (~ 40 %) Rice Bran oil (~42.5%) Gheeb (~ 27 % )
PUFA rich oils n-6 PUFA : Safflower oil (~ 75%) Sunflower oil (~ 55%) Corn oil (~ 55%) Rice Bran oil (~39%) Groundnut oil (~35%)
n-3 PUFA: Linseed oila (~ 55%) Soyabean oila (~7%) Mustard oila(~10%) Rice bran oil (~1%)a Present in the form of -linolenic acid
b290 mg % Cholesterol
16
EFFECT OF FATTY ACIDS
Dietary fatty acids
Blood lipidsBlood
clotting factors
Blood pressureTC LDL HDL TG
Total Fat
(>35en%)
SFA
MUFA
Trans Fat
PUFA (n-6)
PUFA (n-3)+
↑ ↑ ↓ ↑
↑ ↑ NC ↑
↓ ↓ NC NC
↑ ↑ ↓ ↑
↓ ↓ ↓* NC
NC NC NC ↓↓
NC
↑
↓
?
↑
↓↓
↑
↑
↓
?
NC
↓↓ * Intake > 10en% (~22g) + Long chain n-3 PUFA (EPA+DHA) from fish oil NC - no change
17
Non-glyceride fraction (NGF) of oils
+ Tocopherols
Oil NGF (%)
T + Unique components
Functions
Sunflower 1.5
Safflower 1.5
Sesame 2.0 Lignans Hypochol & antioxidant
Palm/red palm
1.2 T3 & carotenes
Antioxidant
Ricebran 4.0 T3 & oryzanol Hypochol & antioxidant
Groundnut 1.0 ,
Mustard 1.5 ,
Soyabean 1.5 , ,
18
Dietary intervention trails on CHD risk
Trail Subject Dietary Duration Change inIntervention years CHDa
DART 1015 MI Total fat 2 -9%Patients males
Finnish mental 676 males unsaturated 6 -43%Hospital saturated
Los Angels 426males ,, 8 -31%Veteran
Oslo Diet 206 MI ,, 5 -25%Heart Study patients males
MRC Soy oil 199 MI ,, 4 -12%Patients males
Lycon Diet 302 MI Mediterranean 2 -73%Heart Study Patient males Diet
a change in CHD refers to the percentage difference in coronary event rates in the treatment compared to control group
19
Low CHD mortality in Mediterranean population
who use olive oil as the primary source of fat
MUFA plasma cholesterol
MUFA enriched LDL is more resistant to oxidative
modification
Dietary MUFA prothrombotic environment by
plasminogen activator inhibitor-1
Monounsaturated Fatty Acids & CHD Risk
20
ATHEROGENIC LIPOPROTEIN PHENOTYPE
Elevated level of circulating triglycerides in both
fasted and postprandial state
Reduction of HDL and increase of LDL-3 (small,
dense LDL)
Commonly observed in diabetics and those with
metabolic syndrome
Associated with a two to three fold increased
CHD risk
21
Two groups of n-3 PUFA
-Linolenic acid(C18:3 n-3) derived from plant oils (linseed oil, soybean oil, mustard oil)
Marine n-3 PUFA such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) derived from sea
food
-Linolenic acid is elongated & desaturated to EPA and DHA
n-3 PUFA
22
Metabolic effects of n-6 and n-3 PUFA are different
n-6 PUFA more effective in plasma lipids
Eicosanoids derived from n-3 PUFA are anti-
atherothrombogenic compared to that of n-6 PUFA
n-6 and n-3 PUFA compete each other for desaturation
and chain elongation pathway
Optimal balance between n-6 and n-3 PUFA in the diet is
important
RELATIVE SIGNIFICANCE OF n-6 AND n-3 PUFA
23
FAT IN INDIAN DIETS
Diet of rural poor invisible fat from cereals and pulses alone
provide 7en% fat (16g), 2en% LA (4g) and 0.2 en% ALNA (0.4g)
Diet of urban high income invisible fat from all food items
furnish 12en% fat (27g)
The visible fat requirements for Indians ranges between 20 and
50g
Current daily intake of visible fat highly skewed with rural and
urban poor consuming < 12g urban high income group
consuming > 40g/person
24
n-6 PUFA nutritional status is good
whereas n-3 PUFA nutritional status needs
to be improved
Can be achieved by Selecting vegetable oils which provides both LA and ALNA
Increasing plant foods which are good source of ALNA
Preferring fish over other non-vegetarian foods
25
QUANTITIES OF SELECTED FOODS WHICH PROVIDE 0.1g ALNA
Foods gm
Cereal/milletWheat&Bajra 70
PulsesBlackgram, Rajmah & Cowpea 20
VegetablesGreen leafy 60Other vegetables 400
SpicesFenugreek seed 5Mustard seeds 1
Unconventional foodsFlaxseed 0.5Perilla seed 0.3
26
CURRENT RECOMMENDATIONS OF DIETARY FAT INTAKE
WHO/FAO ( 2003) recommendations
Total fat 15-30 en% (33-67g)
Saturated Fat <10en%(22g); <7en%(16g) in high risk individuals
Total MUFA 10-12 en% (22-27g)*
Trans Fat <1en% (2g)
Total PUFA up to 10en% (22g)
LA ( n-6 PUFA) 3-8en% (7-18)
ALNA (n-3 PUFA) 1-2.5 en% (2-6g)
PUFA/SFA ratio 0.8 to 1.0
n-6/n-3 ratio 2.5:1-8:1
Cholesterol < 200mg
* ADA recommends up to 20en% (44g) in the diabetic diet
27
Oil combinations Proportion
Groundnut/Sesame/RBO : Mustard 3:1
Groundnut/Sesame/RBO : Canola 2:1
Groundnut/Sesame/RBO : Soybean 2:1
Palmolein : Soybean 1:1
Safflower : Palmolein : Mustard 1:1:1
RECOMMENDED OIL COMBINATIONS FOR OPTIMAL HEALTH BENEFITS
28
Reduced or modified dietary fat for preventing cardiovascular disease (Review) 1
Copyright © 2008 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd
Objectives:
The aim of this systematic review was to assess the
effect of reduction or modification of dietary fats on
total and cardiovascular mortality and cardiovascular
morbidity over at least 6 months, using all available
randomized clinical trials.
29
Main results
Twenty seven studies were included (40 intervention arms, 30,901 person-years).
There was no significant effect on total mortality
Trend towards protection form cardiovascular mortality
30
Main results
Significant protection from cardiovascular events
Trials where participants were involved for more than 2 years showed significant reductions in the rate of cardiovascular events and a suggestion of protection from total mortality.
The degree of protection from cardiovascular events appeared similar in high and low risk groups, but was statistically significant only in the former.
31
Degree of lipid lowering-1
It is well established that lipid lowering(20% +) through use of statins does have a protective effect on people at high risk of cardiovascular disease.
Statin trials have shown a highly significant 25 per cent fall in coronary heart disease mortality (Ebrahim 1998).
32
Degree of lipid lowering-2
Dietary trials used for this review the mean
individual initial total serum cholesterol level
was 5.8 mmol/litre, and the average change over
the trial was a fall of 0.64mmol/litre (11.1%).
Relatively small degree of lipid lowering may be
a reason that no significant effect of dietary fat
intervention was seen on total or cardiovascular
mortality in the short term.
33
Dietary Interventions-1
Low fat, high carbohydrate diets Result in higher
triglyceride and lower HDL cholesterol levels than a
diet where saturated fats are wholly replaced by
unsaturated fats (Mensink 1992).
34
Dietary Interventions-2
Interventions on dietary fat need to result in useful
levels of cholesterol reduction and these must be
sustained for at least two years to have an impact
on levels of cardiovascular events.
It is not clear whether there is additional benefit of
modifying dietary fat in those at high risk of
cardiovascular disease who are on statins to
reduce their cholesterol levels.
35
Mayo Clinic cardiologist Gerald Gau, M.D.,
The extent to which dietary cholesterol raises blood cholesterol levels isn't clear.
Saturated fats and trans fats have a greater impact than does dietary cholesterol in raising blood cholesterol.
If you are healthy, it's recommended that you limit your dietary cholesterol intake to less than 300 mg a day.
If you have cardiovascular disease, diabetes or high LDL (or "bad") cholesterol, you should limit your dietary cholesterol intake to less than 200 mg a day.
If you eat an egg on a given day, it's important to limit or avoid other sources of cholesterol for the rest of that day.
If you like eggs but don't want the extra cholesterol, use egg whites.
If you want to reduce cholesterol in a recipe that calls for eggs, use two egg whites.
Eggs: Are they good or bad for my cholesterol?
36
Increase Soluble Fiber.
Decrease Saturated & Trans Fat.
Increase Tree nuts.
Increase MUFA and n-3
Increase Fruits & Vegetables
Dietary Recommendations